Webinars

3 Steps to a Safe Data Strategy

Strategy development can hold you back. You want to leverage your organization’s data assets, including those containing sensitive information, but you can’t get consensus on how to…

The Future of Clinical Trial Transparency

In this session, we’ll discuss three emergent trends destined to have a major impact on your transparency planning for 2021.

Be a Change Agent, Not a Secret Agent

As the healthcare industry evolves into an ecosystem of data-rich, digitally enabled stakeholders, drug manufacturers are losing their informational advantage in the value chain.

Beyond Data Transparency: Innovation Across the Drug Development Lifecycle

Once a drug company has clinical trial transparency (CTT) capabilities in place, new opportunities to drive value further along the drug development life cycle also emerge.

Patients, Privacy and Competitive Advantage

How effective is your organization at leveraging data across the entirety of the drug development cycle?

Spur Pharmaceutical Insights with NLP and Anonymization Services

Extracting the value from unstructured data and addressing privacy concerns are common challenges organizations face when trying to glean insights from data.

Privacy, Mobility, & Policy: Understanding Re-identification Risks in Mobility Data

Questions of how re-identifiable mobility data is—and whether individual location traces can be sufficiently anonymized—have become increasingly prominent as governments around the world seek to ...

Are you utilizing patient data to its full potential?

While structured data is now commonly deidentified and used for a multitude of purposes, it’s only part of the story.

MIT CDOIQ Symposium Panel Session - Safely Turn Sensitive Data into Business Opportunity

How can companies leverage the increasing business value of the sensitive data they manage (without running afoul of statutory regulations, or stakeholder trust)?

Earning Trust to Innovate with Sensitive Data

This is a co-presentation by global authorities in data and privacy, ending with a thorough, facilitated Q&A session. In the presentation, our experts share specific data privacy strategies and ...

Filter by Data Type

Categories